TUS-STRAT: CRP and Thoracic Emergency Ultrasound in Pneumonia

Sponsor
Azienda Ospedaliera, Universitaria Policlinico Vittorio Emanuele (Other)
Overall Status
Completed
CT.gov ID
NCT03212248
Collaborator
Ospedale Civile di Ragusa, Italy (Other)
70
1
17.9
3.9

Study Details

Study Description

Brief Summary

This preliminary study investigates in patients with possible clinical diagnosis of pneumonia, clues and biomarker assessed at Emergency Department (ED) triage, potentially predicting detection of lung consolidation by Thoracic-ultrasound (TUS) and/or by Chest-X-Rays. Cough and high admission CRP levels will be defined according to the cutoff defined by ROC analysis, will be challenged if independently associated with TUS lung consolidation detection High level of the chosen biomarker, and any of the considered symptoms, in otherwise not extremely critical patients (CURB65≤3), should prompt to immediate confirm by TUS, during the physical examination. This may limit the need of further radiological investigations allowing targeted workup.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Thoracic Ultrasound (TUS)

Detailed Description

Chest-X-Rays (CXR), Computerized Tomography (CT) or Thoracic Ultrasound (TUS) provide images deemed consistent with acute lung consolidation and suitable to confirm the diagnosis of community acquired pneumonia (CAP). Patients which may be affected by CAP are many , but diagnosis is not straightforward because we are managing "a disease characterized by educated guesswork" . Comprehensive imaging workup may be not regularly affordable in busy emergency rooms. Point-of-care TUS allows reliable diagnosis of lung consolidation and of pleural effusion. Regretfully, adequate TUS expertise is more warranted than actually available in most medical departments. Even not specifically investigated, a delay or even an impairment of appropriate TUS or CXR evaluation for several patients may occur due to time- or resource-limiting factors.

Clinical clues of lung consolidation are many. Key symptoms are cough, fever, chest pain and dyspnea with tachypnea, while the major physical signs are chest crackles and dullness. Surrogate biomarkers more easily obtainable in emergency facilities are C-reactive-protein (CRP), peripheral non-invasive pulse-oxymetry and neutrophil-to-lymphocyte ratio (NLR) which is an index of systemic inflammation associated also with pneumonia and subsequent outcome.

The aim of this preliminary study is to evaluate if any clue and which biomarker, including NLR, assessed at Emergency Department (ED) triage, is predictive of the subsequent detection of lung consolidation by TUS and/or by CXR.

The minimal groups' size, with and without TUS or CXR lung consolidation, was calculated according to the difference of the averages of neutrophil-to-lymphocyte ratio (NLR) in the reference the study of Yoon et al. Accepting alpha 0.01, for the probability of type 1 error, and power 80% for probability of type 2 error, a minimum sample size of 19 participants in each group (total 38) was required. Student's t-tests assessed the differences of CRP, WBC - white blood cells count - (TLC), neutrophil count (TNC) and NLR, between the groups with TUS and, separately, with CXR lung consolidation.Thereafter, by ROC (receiver operating curve) analysis, a cutoff of NLR, total leucocytes count (TLC), total Neutrophil count (TNC) and of CRP was calculated vs. the optimal reliability for the detection of TUS consolidation; sensitivity, specificity and accuracy (The proportion of all tests that are correct), and relative Odds Ratio (OR) and confidence intervals (CI) of the individual symptoms, and ORs of so defined laboratory assay cut-offs were calculated separately vs. TUS and CXR consolidation.

Study Design

Study Type:
Observational
Actual Enrollment :
70 participants
Observational Model:
Case-Only
Time Perspective:
Prospective
Official Title:
CRP (C-Reactive-Protein) and Pneumonia Biomarkers Stratification for Selectively Addressing Priorities in Thoracic Emergency Ultrasound in Pneumonia
Actual Study Start Date :
Jan 2, 2016
Actual Primary Completion Date :
Apr 30, 2016
Actual Study Completion Date :
Jun 30, 2017

Outcome Measures

Primary Outcome Measures

  1. Odds of detecting lung consolidation by TUS according to symptoms or biomarkers' cutoffs [ten minutes]

    ultrasound

Secondary Outcome Measures

  1. Odds of detecting lung consolidation by Chest X Rays (CXR) according to symptoms or biomarkers' cutoffs [ten minutes]

    radiology

Eligibility Criteria

Criteria

Ages Eligible for Study:
19 Years to 75 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:

presence of history and symptoms, signs at physical examination and early laboratory clues of CAP According to the preliminary triage, in all patients, as a routine assessment, breath frequency, blood pressure and heart rate, pulse oxymetry, serum and blood analysis including creatinine and urea, CRP, blood cell counts and hemoglobin assay, were performed, also for CURB65 staging. ECG was preliminary done in all patients with chest pain, dyspnea and/or fever.

Exclusion Criteria:

Contacts and Locations

Locations

Site City State Country Postal Code
1 MCAU Catania Please select an option below Italy 95131

Sponsors and Collaborators

  • Azienda Ospedaliera, Universitaria Policlinico Vittorio Emanuele
  • Ospedale Civile di Ragusa, Italy

Investigators

  • Study Chair: GUGLIELMO TROVATO, MD, medint

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Guglielmo Trovato, MD, PhD, Professor of Medicine - Research Project Planning Unit, Azienda Ospedaliera, Universitaria Policlinico Vittorio Emanuele
ClinicalTrials.gov Identifier:
NCT03212248
Other Study ID Numbers:
  • TUS-STRAT
First Posted:
Jul 11, 2017
Last Update Posted:
Jul 11, 2017
Last Verified:
Jul 1, 2017
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 11, 2017